Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to $2.0 million.

  • Nexgel's Operating Expenses rose 128.67% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 4197.69%. This contributed to the annual value of $6.3 million for FY2024, which is 6364.58% up from last year.
  • Latest data reveals that Nexgel reported Operating Expenses of $2.0 million as of Q3 2025, which was up 128.67% from $1.9 million recorded in Q2 2025.
  • Nexgel's Operating Expenses' 5-year high stood at $2.0 million during Q3 2025, with a 5-year trough of $478000.0 in Q1 2021.
  • For the 5-year period, Nexgel's Operating Expenses averaged around $1.2 million, with its median value being $1.0 million (2021).
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 11428.57% in 2022, then tumbled by 1932.49% in 2023.
  • Quarter analysis of 5 years shows Nexgel's Operating Expenses stood at $991000.0 in 2021, then increased by 19.58% to $1.2 million in 2022, then decreased by 4.47% to $1.1 million in 2023, then skyrocketed by 69.17% to $1.9 million in 2024, then rose by 2.77% to $2.0 million in 2025.
  • Its Operating Expenses stands at $2.0 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.0 million for Q1 2025.